Trial NCT01148810

View at ClinicalTrials.gov 
Org. Study IDs: CBAF312A2202
Secondary IDs: 2008-006311-21

Last trial update was posted on 2019-04-25

MeSH Interventions

Siponimod

MeSH Conditions

Dermatomyositis Polymyositis

Other Conditions


Stopping Reasons

Trial was prematurely terminated due to enrollment challenges.

Limitations And Caveats

The study was terminated due to new clinical data from overall BAF312 program (<10 mg/day already have optimal pharmacodynamic effect & clinical efficacy). There was no safety concern testing 10 mg BAF312 that would have required study termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID